Modification to the Basic Center Program Funding Opportunity Announcement, 39953-39954 [2010-17069]
Download as PDF
39953
Federal Register / Vol. 75, No. 133 / Tuesday, July 13, 2010 / Notices
Testing Communications on Medical
Devices and Radiation-Emitting
Products—(OMB Control Number 0910–
New)
FDA is authorized by section
1003(d)(2)(D) of the Federal Food, Drug,
and Cosmetic Act (the act) (21 U.S.C.
393(d)(2)(D)) to conduct educational
and public information programs
relating to the safety of regulated
medical devices and radiation-emitting
products. FDA must conduct needed
research to ensure that such programs
have the highest likelihood of being
effective. Improving communications
about medical devices and radiationemitting products will involve many
research methods, including individual
indepth interviews, mall-intercept
interviews, focus groups, selfadministered surveys, gatekeeper
reviews, and omnibus telephone
surveys.
The information collected will serve
three major purposes. First, as formative
research it will provide critical
knowledge needed about target
audiences to develop messages and
campaigns about medical device and
radiation-emitting product use.
Knowledge of consumer and health care
professional decisionmaking processes
will provide the better understanding of
target audiences that FDA needs to
design effective communication
strategies, messages, and labels. These
communications will aim to improve
public understanding of the risks and
benefits of using medical devices and
radiation-emitting products by
providing users with a better context in
which to place risk information more
completely.
Second, as initial testing, it will allow
FDA to assess the potential effectiveness
of messages and materials in reaching
and successfully communicating with
their intended audiences. Testing
messages with a sample of the target
audience will allow FDA to refine
messages while still in the
developmental stage. Respondents will
be asked to give their reaction to the
messages in either individual or group
settings.
Third, as evaluative research, it will
allow FDA to ascertain the effectiveness
of the messages and the distribution
method of these messages in achieving
the objectives of the message campaign.
Evaluation of campaigns is a vital link
in continuous improvement of
communications at FDA.
FDA estimates the burden of this
collection of information as follows:
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN
Section of the act
No. of
Respondents
Annual Frequency
per Response
Total Annual
Responses
Hours per
Response
Total
Hours
Total Operating &
Maintenance
Costs1
1003(d)(2)(D)
16,448
1
16,448
0.1739
2,860
$25,239
Total
16,448
1
16,448
0.1739
2,860
$25,239
1 There
are no capital costs associated with this collection of information.
Annually, FDA projects about 30
studies using a variety of research
methods, and lasting an average of 0.17
hours each (varying from 0.08–1.5
hours). The operating and maintenance
costs include contractor expenses for
designing and conducting information
collection activities, specifically,
drawing samples, training interviewers,
collecting and analyzing information,
and reporting and disseminating
findings. FDA estimates the burden of
this collection of information based on
prior recent experience with the various
types of data collection methods
described earlier. FDA is requesting this
burden so as not to restrict the agency’s
ability to gather information on public
sentiment for its proposals in its
regulatory and communications
programs.
Dated: July 7, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
jlentini on DSKJ8SOYB1PROD with NOTICES
[FR Doc. 2010–16973 Filed 7–12–10; 8:45 am]
BILLING CODE 4160–01–S
VerDate Mar<15>2010
16:44 Jul 12, 2010
Jkt 220001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Modification to the Basic Center
Program Funding Opportunity
Announcement
Program Office: Administration on
Children, Youth, & Families—Family &
Youth Services Bureau.
Funding Opportunity Title: Basic
Center Program.
Announcement Type: Modification.
Funding Opportunity Number: HHS–
2010–ACF–ACYF–CY–0002.
CFDA Number: 93.623.
Due Date for Applications:
07/19/2010.
This is a Modification to the Basic
Center Program Funding Opportunity
Announcement (FOA), HHS–2010–
ACF–ACYF–CY–0002, published to the
ACF Grant Opportunities webpage on
June 2, 2010, https://www.acf.hhs.gov/
grants/open/foa/view/HHS-2010-ACFACYF-CY-0002. A modified FOA that
incorporates the following changes was
published to the ACF Grant
Opportunities webpage on June 25,
2010. The application procedures are
hereby modified.
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
SUMMARY: The Family and Youth
Services Bureau (FYSB) is accepting
applications for the Basic Center
Program (BCP), which is authorized by
the Runaway and Homeless Youth Act
to address Runaway and Homeless
Youth (RHY) problems. BCPs provide an
alternative for runaway and homeless
youth who might otherwise end up with
law enforcement or in the child welfare,
mental health, or juvenile justice
systems. Each BCP must provide
runaway and homeless youth with a
safe and appropriate shelter; individual,
family, and group counseling, as
appropriate; and aftercare.
The purpose of the modification is to
correct information appearing in Section
IV.2 Content and Form of Application
Submission regarding application
formatting and point deduction for
noncompliance with FOA instructions.
Modification to the Published
Announcement
Please delete the following under
Section IV.2. Content and Form of
Application Submission:
‘‘Applicants that do not adhere to the
prescribed format will have points deducted
from the overall total after the grant review:
Program narrative (which includes
Objective and Need for Assistance, Results
and Benefits, Approach, Organizational
Profile, Staff and Position Data, and Budget
E:\FR\FM\13JYN1.SGM
13JYN1
39954
Federal Register / Vol. 75, No. 133 / Tuesday, July 13, 2010 / Notices
Justification) is not double spaced: Deduction
of 5 points.
Margins less than 1⁄2 inch: Deduction of 3
points.
Font is not at least 12-point size or Times
New Roman: Deduction of 2 points.’’
Please replace the deleted language
under Section IV.2. Content and Form of
Application Submission with the
following:
‘‘Applications that do not adhere to the
prescribed format will be converted to
conform with the prescribed format. Should
the conversion result in a document which
exceeds 90 pages, all pages exceeding the 90page limit will be removed and will not be
considered in the reviewing process.’’
All information in this modification is
accurate and replaces information
specified in the June 2, 2010 Funding
Opportunity Announcement.
Announcement Availability: To access
this Program Announcement please go
to the ACF Grant Opportunities
webpage at https://www.acf.hhs.gov/
grants/ or to https://
www.Grants.gov.
FOR FURTHER INFORMATION CONTACT:
Victoria Marquez at 202–205–4866 and
Victoria.Marquez@acf.hhs.gov.
Dated: July 1, 2010.
Bryan Samuels,
Commissioner, Administration on Children,
Youth and Families.
[FR Doc. 2010–17069 Filed 7–12–10; 8:45 am]
BILLING CODE 4182–04–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0274]
Food and Drug Administration,
HHS.
jlentini on DSKJ8SOYB1PROD with NOTICES
ACTION:
I. Background
In the Federal Register of June 17,
2010 (75 FR 34463), FDA published a
notice announcing a public meeting that
is intended to create a forum for
interested stakeholders to discuss the
agency’s oversight of laboratory
developed tests. FDA announced in the
notice that it is seeking input and
requesting comments on this topic. The
June 17, 2010, notice invited
individuals interested in presenting to
register by July 12, 2010. Registration to
present at the public meeting is closed.
All others are welcome to attend on a
first-come, first-served basis.
Because of greater than anticipated
response for attending the public
meeting, FDA is announcing in this
notice a new location for the public
meeting.
II. New Location for the Public
Workshop
The new location will be The Marriott
Inn & Conference Center, University of
Maryland University College (see
ADDRESSES). Directions and information
on parking, accommodations, and
transportation options can be found at:
https://www.marriott.com/hotels/travel/
wasum-the-marriott-inn-andconference-center-university-ofmaryland-university-college/.
Dated: July 7, 2010.
Nancy Stade,
Acting Associate Director for Regulations and
Policy, Center for Devices and Radiological
Health.
Oversight of Laboratory Developed
Tests; Public Meeting; Change of
Meeting Location
AGENCY:
FOR FURTHER INFORMATION CONTACT:
Katherine Serrano, Center for Devices
and Radiological Health, Food and Drug
Administration 10903 New Hampshire
Ave., Bldg. 66., rm 5613, Silver Spring,
MD 20993–0002, 301–796–6652, e-mail:
Katherine.serrano@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2010–16974 Filed 7–12–10; 8:45 am]
BILLING CODE 4160–01–S
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing a
change in location for the upcoming
public meeting entitled ‘‘Oversight of
Laboratory Developed Tests.’’ A new
address is given for those attending the
public meeting.
DATES: The public meeting will be held
on July 19 and 20, 2010, from 8 a.m. to
5 p.m. each day.
ADDRESES: The public meeting will be
held at The Marriott Inn & Conference
Center, University of Maryland
University College, 3501 University
Blvd. E, Hyattsville, MD 20783.
VerDate Mar<15>2010
16:44 Jul 12, 2010
Jkt 220001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of a
Conference Call of the NIH Scientific
Management Review Board
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a conference call
meeting of the Scientific Management
Review Board.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
The NIH Reform Act of 2006 (Pub. L.
109–482) provides organizational
authorities to HHS and NIH officials to:
(1) Establish or abolish national research
institutes; (2) reorganize the offices
within the Office of the Director, NIH
including adding, removing, or
transferring the functions of such offices
or establishing or terminating such
offices; and (3) reorganize, divisions,
centers, or other administrative units
within an NIH national research
institute or national center including
adding, removing, or transferring the
functions of such units, or establishing
or terminating such units. The purpose
of the Scientific Management Review
Board (also referred to as SMRB or
Board) is to advise appropriate HHS and
NIH officials on the use of these
organizational authorities and identify
the reasons underlying the
recommendations.
Name of Committee: Scientific
Management Review Board.
Date: July 26, 2010.
Time: 10:30 a.m. to 12 p.m. (EST)
Agenda: Presentation will include an
overview and discussion of a new charge to
the SMRB, which entails considering the
attributes and functions of a translational
medicine program optimized to accelerate
therapeutics development. Time will be
allotted on the agenda for public comment.
To sign up for public comment, please
submit your name and affiliation to the
contact person listed below by July 25, 2010.
Sign up will be restricted to one sign up per
email. In the event that time does not allow
for all those interested to present oral
comments, anyone may file written
comments using the contact person address
below.
Dial-In Information: The toll-free number
to participate in this call is 1–800–779–1545.
Indicate to the conference operator that your
participant pass code is ‘‘NIH’’.
Contact Person: Dr. Lyric Jorgenson, Office
of Science Policy, Office of the Director, NIH,
National Institutes of Health, 6705 Rockledge
Drive, Suite 750, Bethesda, MD 20892, (301)
496–6837, smrb@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
The draft agenda, meeting materials, dialin information, and other information about
the SMRB, will be available at https://
smrb.od.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93,936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
E:\FR\FM\13JYN1.SGM
13JYN1
Agencies
[Federal Register Volume 75, Number 133 (Tuesday, July 13, 2010)]
[Notices]
[Pages 39953-39954]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-17069]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Modification to the Basic Center Program Funding Opportunity
Announcement
Program Office: Administration on Children, Youth, & Families--
Family & Youth Services Bureau.
Funding Opportunity Title: Basic Center Program.
Announcement Type: Modification.
Funding Opportunity Number: HHS-2010-ACF-ACYF-CY-0002.
CFDA Number: 93.623.
Due Date for Applications: 07/19/2010.
This is a Modification to the Basic Center Program Funding
Opportunity Announcement (FOA), HHS-2010-ACF-ACYF-CY-0002, published to
the ACF Grant Opportunities webpage on June 2, 2010, https://www.acf.hhs.gov/grants/open/foa/view/HHS-2010-ACF-ACYF-CY-0002. A
modified FOA that incorporates the following changes was published to
the ACF Grant Opportunities webpage on June 25, 2010. The application
procedures are hereby modified.
SUMMARY: The Family and Youth Services Bureau (FYSB) is accepting
applications for the Basic Center Program (BCP), which is authorized by
the Runaway and Homeless Youth Act to address Runaway and Homeless
Youth (RHY) problems. BCPs provide an alternative for runaway and
homeless youth who might otherwise end up with law enforcement or in
the child welfare, mental health, or juvenile justice systems. Each BCP
must provide runaway and homeless youth with a safe and appropriate
shelter; individual, family, and group counseling, as appropriate; and
aftercare.
The purpose of the modification is to correct information appearing
in Section IV.2 Content and Form of Application Submission regarding
application formatting and point deduction for noncompliance with FOA
instructions.
Modification to the Published Announcement
Please delete the following under Section IV.2. Content and Form of
Application Submission:
``Applicants that do not adhere to the prescribed format will
have points deducted from the overall total after the grant review:
Program narrative (which includes Objective and Need for
Assistance, Results and Benefits, Approach, Organizational Profile,
Staff and Position Data, and Budget
[[Page 39954]]
Justification) is not double spaced: Deduction of 5 points.
Margins less than \1/2\ inch: Deduction of 3 points.
Font is not at least 12-point size or Times New Roman: Deduction
of 2 points.''
Please replace the deleted language under Section IV.2. Content and
Form of Application Submission with the following:
``Applications that do not adhere to the prescribed format will
be converted to conform with the prescribed format. Should the
conversion result in a document which exceeds 90 pages, all pages
exceeding the 90-page limit will be removed and will not be
considered in the reviewing process.''
All information in this modification is accurate and replaces
information specified in the June 2, 2010 Funding Opportunity
Announcement. Announcement Availability: To access this Program
Announcement please go to the ACF Grant Opportunities webpage at https://www.acf.hhs.gov/grants/ or to https://www.Grants.gov.
FOR FURTHER INFORMATION CONTACT: Victoria Marquez at 202-205-4866 and
Victoria.Marquez@acf.hhs.gov.
Dated: July 1, 2010.
Bryan Samuels,
Commissioner, Administration on Children, Youth and Families.
[FR Doc. 2010-17069 Filed 7-12-10; 8:45 am]
BILLING CODE 4182-04-P